Have you seen our latest case study? It touches on six of our twelve service areas and follows the experience of a client who is new to C&GT (though otherwise practiced in late stage processes). That client required CRL remediation to prepare for BLA resubmission. Read more here!

Cell & Gene Therapy Specialists

Our team of experienced cell and gene therapy professionals bring deep domain expertise to assist our clients in achieving their strategic and operational objectives.


We apply pharmaceutical industry best practices to the unique challenges of the Cell and Gene Therapy (C&GT) field. Our team can help you with a wide range of needs, spanning from high level corporate strategy development to detailed technical implementation.

We have a dozen commonly-requested services, listed below.

During 2020, we released 20 case studies (green buttons below) to provide you with concrete examples of how our expertise can support your business. The first 2021 case study, Remediation of CRL issues for BLA Resubmission, is applicable to six of our twelve service areas so we’re placing it up top, here, for clear and easy access.

  • Method development
  • Specification setting
  • Method transfer
  • Qualification & validation
  • Remediation
  • Comparability testing
  • Capacity planning
  • Cost-of-goods analysis
  • Build vs. Buy analytics

  • QMS design and strategy
  • QMS gap assessment
  • Document authoring, review, and revision
  • Supplier oversight
  • Audits (see flyer below)
  • URS development
  • Landscape scan & gap analysis
  • Custom device design
  • Contract manufacturing management
  • DHF & DMF development
  • Preclinical strategy
  • Study design and oversight
  • Vendor selection
  • Technical writing
  • Critical path identification
  • Project management
  • Strategic project planning
  • Stage-gating
  • Needs assessment
  • Voice of customer surveys
  • Marketing strategy

  • Strategic portfolio
    assessment & analysis
  • Landscape analysis and competitive intelligence
  • IP due diligence
  • IP strategy

The wheel of DHC services tells us it’s time for the #DHCmanuf #DHCdeepdive! Developers often find identifying/implementing an optimal cGMP manuf strategy to be an unexpected challenge, so let’s spend this wk looking at points of consideration for getting ahead of the game. (1/4)

What better to follow the topic of #DHCprocessdev than what comes next in the cycle of C&GT dev? Next wk's #DHCdeepdive focuses on #DHCmanuf. We'll talk abt common project types in conjunction with relevant case studies & share a new in-person profile! http://bit.ly/DHCmanuf

It's another two-part Monday hello to some new Dark Horses! Today we welcome:
1) Consultant Lyndsey Atkins (https://darkhorseconsultinggroup.com/lyndsey-atkins-2/), who will enrich our UK office with her significant quality assurance, computer system validation, and clinical trial oversight experience, and

Today, to complete this week's #DHCprocessdev #DHCdeepdive, we're introducing you "in person" to three Consultants who came to Dark Horse just this year and who all have a specific career emphasis on process development.
Alphabetically...we'll begin with (1/4)

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.